Ovid Therapeutics Inc

Research Ovid Therapeutics Inc (OVID) on Bullrun: market cap USD 507.66M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOVID
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 507.66M
• Financial periodFY2025
• RevenueUSD 7.25M
• Revenue growth1181.3%
• Net income-USD 17.40M
• Free cash flow-USD 38.33M

Valuation Snapshot

latest market cap is USD 507.66M.

About Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies;

Frequently asked questions

What is Ovid Therapeutics Inc's market cap?

Ovid Therapeutics Inc's market capitalization is USD 507.66M.

What does Ovid Therapeutics Inc do?

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States.